Insilico Medicine Analysis: $510M Raised
What is Insilico Medicine?
Generative AI for drug discovery and sustainability
HQ Country
Seattle, United States
Employees
1-10
Founded
2003
HQ State/Province
Washington
Funding Category
Series E
HQ Full Address
111 Queen Anne Avenue North, Seattle, Washington 98019, United States
Product Features & Capabilities
- PandaOmics
- PandaOmics Box
- Chemistry42
- Generative Biologics
- Science42: DORA
- inClinico
- PreciousGPT
Other Considerations
Recognized as the most innovative biotechnology company in the world 2024; Engaged in over 20 drug discovery programs; Collaborates with major global enterprises; Holds multiple proprietary technologies in AI-driven drug discovery
